<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01501331</url>
  </required_header>
  <id_info>
    <org_study_id>PTVCARDIO2011_01</org_study_id>
    <nct_id>NCT01501331</nct_id>
  </id_info>
  <brief_title>Multiparametric Heart Failure Evaluation in Internal Cardioverter Defibrillators (ICD) Patients</brief_title>
  <acronym>MULTITUDE-HF</acronym>
  <official_title>Multiparametric Evaluation of Heart Failure in Device-implanted Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rome Tor Vergata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rome Tor Vergata</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Boston Scientific Energen family is capable of measuring the respiratory rate trend (RRT)
      on a daily basis and transmission of data via the Remote Monitoring technology. This may
      result in early detection of imminent decompensation at a presymptomatic stage. The study
      will assess the respiratory trends correlation with clinically relevant heart failure events.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prediction by RRT of cardiovascular death or rehospitalization for worsening of heart failure symptoms.</measure>
    <time_frame>24 months</time_frame>
    <description>Respiratory rate changes (maximum, median and minimum values) before a primary event (3-, 2-, 1-week before and on the day of the event) will be compared to those at baseline (6 weeks prior the event).
Pts with less than 30-day of RR data or events without sufficient baseline will be excluded from the analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of in-hospital consultations with relevant findings (i.e. necessitating changes in medical therapy, device programming or re-hospitalisations/ interventions)</measure>
    <time_frame>24 months</time_frame>
    <description>Respiratory rate changes (maximum, median and minimum values) before the event (3-, 2-, 1-week before and on the day of the event) will be compared to those at baseline (6 weeks prior the event).
Pts with less than 30-day of RR data or events without sufficient baseline will be excluded from the analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of RRT with appropriate ICD therapy (ATP or Shock)</measure>
    <time_frame>24 months</time_frame>
    <description>Respiratory rate changes (maximum, median and minimum values) before the event (3-, 2-, 1-week before and on the day of the event) will be compared to those at baseline (6 weeks prior the event).
Pts with less than 30-day of RR data or events without sufficient baseline will be excluded from the analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of RRT with atrial and ventricular arrhythmias</measure>
    <time_frame>24 months</time_frame>
    <description>Respiratory rate changes (maximum, median and minimum values) before the event (3-, 2-, 1-week before and on the day of the event) will be compared to those at baseline (6 weeks prior the event).
Pts with less than 30-day of RR data or events without sufficient baseline will be excluded from the analysis</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>RRT diagnostic tool</arm_group_label>
    <description>Patients implanted with an Energen device or successor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRTD or ICD (Energen)</intervention_name>
    <description>RRT measurement by cardiac resynchronization therapy devices and implantable cardioverter defibrillators</description>
    <arm_group_label>RRT diagnostic tool</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients implanted with an Energen device or successor using the RRT diagnostic
        tool
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient eligible for 1-, 2- or 3-chamber ICD implantation according to current
             guidelines or patient already implanted within the past 45 days with a Energen device
             or successor

          -  Able to provide written informed consent

        Exclusion Criteria:

          -  Life expectancy &lt;12 months

          -  Anticipated non-compliance with the follow-up scheme

          -  Moderate to severe Chronic Obstructive Pulmonary Disease

          -  Primary pulmonary hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni B Forleo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rome Tor Vergata</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luca Santini, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rome Tor Vergata</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2011</study_first_submitted>
  <study_first_submitted_qc>December 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2011</study_first_posted>
  <last_update_submitted>November 16, 2014</last_update_submitted>
  <last_update_submitted_qc>November 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rome Tor Vergata</investigator_affiliation>
    <investigator_full_name>Giovanni B Forleo</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Congestive Heart Failure</keyword>
  <keyword>Cardiac Resynchronization Therapy</keyword>
  <keyword>Internal Cardioverter Defibrillators</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

